GR66581B - - Google Patents
Info
- Publication number
- GR66581B GR66581B GR58323A GR790158323A GR66581B GR 66581 B GR66581 B GR 66581B GR 58323 A GR58323 A GR 58323A GR 790158323 A GR790158323 A GR 790158323A GR 66581 B GR66581 B GR 66581B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7804921A FR2417506A1 (fr) | 1978-02-21 | 1978-02-21 | Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques utiles notamment dans le traitement des troubles du psychisme |
| FR7902286A FR2457286A2 (fr) | 1979-01-30 | 1979-01-30 | Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR66581B true GR66581B (cg-RX-API-DMAC7.html) | 1981-03-27 |
Family
ID=26220449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR58323A GR66581B (cg-RX-API-DMAC7.html) | 1978-02-21 | 1979-02-09 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4250178A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS54130585A (cg-RX-API-DMAC7.html) |
| AU (1) | AU526298B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1096868A (cg-RX-API-DMAC7.html) |
| CH (1) | CH639078A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2906461A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES477852A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2014984B (cg-RX-API-DMAC7.html) |
| GR (1) | GR66581B (cg-RX-API-DMAC7.html) |
| IT (1) | IT1113438B (cg-RX-API-DMAC7.html) |
| LU (1) | LU80937A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL7901333A (cg-RX-API-DMAC7.html) |
| SE (1) | SE446450B (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3368618D1 (en) * | 1982-11-04 | 1987-02-05 | Ici Plc | Process for the extraction of metal values and novel metal extractants |
| US4743605A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase |
| DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
| US5811428A (en) * | 1995-12-18 | 1998-09-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| EP0850228A1 (en) * | 1995-09-01 | 1998-07-01 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| NZ503823A (en) * | 1997-10-27 | 2002-04-26 | Sumitomo Pharma | Amide derivatives and their use in treating retinal neurodegenerative disorders |
| US7504396B2 (en) * | 2003-06-24 | 2009-03-17 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| TW200827346A (en) * | 2006-11-03 | 2008-07-01 | Astrazeneca Ab | Chemical compounds |
| TW200836719A (en) * | 2007-02-12 | 2008-09-16 | Astrazeneca Ab | Chemical compounds |
| UY31627A1 (es) * | 2008-02-04 | 2009-08-31 | Nuevas formas cristalinas del ácido 4-[4-(2-adamantilcarbamoíl)-5-ter-butil-pirazol-1-il]benzoico | |
| MX2010011591A (es) * | 2008-04-22 | 2010-11-09 | Astrazeneca Ab | Pirimidin-5-carboxamidas sustituidas 281. |
| WO2016040508A1 (en) * | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Substituted pyrrolidine carboxamide compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789979A (en) * | 1954-09-22 | 1957-04-23 | Searle & Co | Basically substituted nu-alkyl-2-amino-4-hydroxy-5-pyrimidine carboxamides and salts thereof |
-
1979
- 1979-02-09 GR GR58323A patent/GR66581B/el unknown
- 1979-02-12 US US06/011,752 patent/US4250178A/en not_active Expired - Lifetime
- 1979-02-15 IT IT20206/79A patent/IT1113438B/it active
- 1979-02-19 LU LU80937A patent/LU80937A1/xx unknown
- 1979-02-19 CH CH159879A patent/CH639078A5/fr not_active IP Right Cessation
- 1979-02-19 ES ES477852A patent/ES477852A1/es not_active Expired
- 1979-02-19 CA CA321,796A patent/CA1096868A/en not_active Expired
- 1979-02-20 GB GB7905890A patent/GB2014984B/en not_active Expired
- 1979-02-20 DE DE19792906461 patent/DE2906461A1/de not_active Withdrawn
- 1979-02-20 SE SE7901493A patent/SE446450B/sv not_active IP Right Cessation
- 1979-02-20 AU AU44392/79A patent/AU526298B2/en not_active Ceased
- 1979-02-20 NL NL7901333A patent/NL7901333A/xx not_active Application Discontinuation
- 1979-02-20 JP JP1896279A patent/JPS54130585A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US4250178A (en) | 1981-02-10 |
| SE7901493L (sv) | 1979-08-22 |
| JPS54130585A (en) | 1979-10-09 |
| AU4439279A (en) | 1979-07-19 |
| IT1113438B (it) | 1986-01-20 |
| NL7901333A (nl) | 1979-08-23 |
| DE2906461A1 (de) | 1979-08-23 |
| CH639078A5 (fr) | 1983-10-31 |
| GB2014984A (en) | 1979-09-05 |
| GB2014984B (en) | 1982-06-09 |
| AU526298B2 (en) | 1983-01-06 |
| IT7920206A0 (it) | 1979-02-15 |
| ES477852A1 (es) | 1979-08-01 |
| LU80937A1 (fr) | 1979-10-29 |
| SE446450B (sv) | 1986-09-15 |
| CA1096868A (en) | 1981-03-03 |